Policy
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Forward Look
A New Use for Patient DataGregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
-
Policy Matters
FDA Seeks to Improve Access to Investigational Oncology DrugsProject Facilitate offers assistance to medical professionals who want investigational drugs for their cancer patients.
by Richard Pazdur, MD
-
Policy Matters
NIH-AACR Conference Examines Immunotherapy RisksThe meeting underscored the importance of NIH funding for cancer research.
by Elizabeth KS Barksdale, PhD
-
New Rule Would Require Breast Density Disclosure
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
-
The Crowded Field of Checkpoint Inhibitors
Drug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
-
March 29: The Week in Cancer News
Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.
by Marci A. Landsmann
-
Forward Look
Cancer Patients Can Now Defer Student LoansPayments can be put off during treatment and for six months after.
by Bradley Jones
-
Policy Matters
Eliminating HPV-Related CancerHPV vaccination and screening can help eradicate cervical cancer and other malignancies.
by Anna R. Giuliano, PhD
-
The Patient Perspective
Patient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes